BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7530921)

  • 1. Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.
    Kim D; Durán WN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H399-403. PubMed ID: 7530921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
    Kim DD; Ramírez MM; Durán WN
    Microvasc Res; 2000 Jan; 59(1):7-13. PubMed ID: 10625566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance and exchange microvessels are modulated by different PAF receptors.
    Tomeo AC; Durán WN
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C.
    Kobayashi I; Kim D; Hobson RW; Durán WN
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1214-20. PubMed ID: 8160825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.
    Kim DD; Kleinman DM; Kanetaka T; Gerritsen ME; Nivaggioli T; Weber D; Durán WN
    Microcirculation; 2010 Feb; 17(2):128-36. PubMed ID: 20163539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.
    Hall JM; Brain SD
    Br J Pharmacol; 1994 Oct; 113(2):522-6. PubMed ID: 7530573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-induced arteriolar dilation after tyrosine kinase and nitric oxide synthase inhibition in hamster cheek pouch microcirculation.
    Bertuglia S; Colantuoni A
    J Vasc Res; 1998; 35(4):250-6. PubMed ID: 9701709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin- and substance P-induced edema formation in the hamster cheek pouch is tyrosine kinase dependent.
    Rubinstein I
    J Appl Physiol (1985); 2007 Jul; 103(1):184-9. PubMed ID: 17431087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors modulate agonist-induced vasodilation in the hamster cheek pouch.
    Ikezaki H; Akhter SR; Hong D; Suzuki H; Gao XP; Rubinstein I
    J Appl Physiol (1985); 2000 Mar; 88(3):857-62. PubMed ID: 10710379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
    Kim D; Durán WT; Daniels AJ; Durán WN
    Microvasc Res; 1997 Mar; 53(2):167-72. PubMed ID: 9143549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
    Dillon PK; Durán WN
    Circ Res; 1988 Apr; 62(4):732-40. PubMed ID: 2450695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    Eur J Pharmacol; 2000 Sep; 404(3):387-94. PubMed ID: 10996604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    J Vasc Res; 2002; 39(3):238-45. PubMed ID: 12097822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C modulates microvascular permeability through nitric oxide synthase.
    Ramírez MM; Kim DD; Durán WN
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1702-5. PubMed ID: 8897966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins.
    Svensjö E; Boschcov P; Ketelhuth DF; Jancar S; Gidlund M
    Inflamm Res; 2003 May; 52(5):215-20. PubMed ID: 12813626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of insulin during ischemia-reperfusion injury in hamster cheek pouch microcirculation.
    Colantuoni A; Lapi D; Paterni M; Marchiafava PL
    J Vasc Res; 2005; 42(1):55-66. PubMed ID: 15637441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.